MetaVia to Present DA-1726 Phase 1 Trial Data at Precision Liver Symposium

Bitget2026/10/28 12:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

MetaVia will present Phase 1 trial results for DA-1726 at the Precision Liver Symposium on November 4, 2026, in Denver.
The randomized, placebo-controlled trial showed significant reductions in liver fat and weight, with relative preservation of lean mass.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metavia Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610280831PR_NEWS_USPR_____NY82637) on October 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

MetaVia to Present DA-1726 Phase 1 Trial Data at Precision Liver Symposium

You may also like

Crypto prices